West Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow WST
West Pharmaceutical Services, Inc. (WST) Current ratio
West Pharmaceutical Services, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 2.8×, down 0.2× from fiscal 2025 (3.0×). Over the past ten years it has ranged from 2.1× (fiscal 2015) to 3.7× (fiscal 2022); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.0× | 8.09% |
| FY2024 | 2.8× | (3.05%) |
| FY2023 | 2.9× | (22.07%) |
| FY2022 | 3.7× | 26.13% |
| FY2021 | 2.9× | 7.45% |
| FY2020 | 2.7× | (11.95%) |
| FY2019 | 3.1× | (1.69%) |
| FY2018 | 3.2× | 18.51% |
| FY2017 | 2.7× | (0.13%) |
| FY2016 | 2.7× | 24.26% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 2.8× | 4.12% |
| Mar 2026 | 2.7× | (10.27%) |
| Dec 2025 | 3.0× | 5.27% |
| Sep 2025 | 2.9× | 3.21% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| RGEN Repligen Corporation compare | 9.1× |
| MDLN Medline Inc. compare | 4.3× |
| RMD ResMed Inc. compare | 3.1× |
| WST West Pharmaceutical Services, Inc. | 2.8× |
| ALC Alcon compare | 2.1× |
| BAX Baxter International Inc. compare | 1.9× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| SOLV Solventum Corporation compare | 1.0× |
| BDX Becton, Dickinson and Company compare | 0.9× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement